Dormir Inc, Carmel, Ind, a provider of sleep diagnostic services, therapy, and equipment, closed a Series-A financing round of $12 million with participation from venture capital firms active in health care services for sleep lab expansion. The proceeds will be used to expand Dormir’s presence in additional locations around the United States.
Currently, Dormir has 32 sleep diagnostic centers operating under the company’s [removed]MD Sleep[/removed] subsidiary, as well as 31 distribution sites within its CardioSom subsidiary, which provide respiratory devices and equipment to patients with sleep apnea.
CHL Medical Partners is the lead investor in the Series-A financing round. Noro-Moseley Partners and Excel Venture Management joined CHL in the round.
“We are very pleased to be partnering with CHL, Noro-Moseley, and Excel in this financing round, which will provide Dormir with the resources to expand our commercial operations more broadly across the country, via additional sleep centers and distribution sites, joint ventures and acquisitions,” said Timothy Miller, Dormir’s chief executive officer, in an announcement. “We believe that our fully integrated approach for addressing sleep disorders provides a better continuum of care to patients, potentially resulting in a higher compliance rate and better patient outcomes.”